These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 30338511)
41. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Gabrielli L; de Almeida Mda C; Aquino EM Maturitas; 2015 Jul; 81(3):398-405. PubMed ID: 26004079 [TBL] [Abstract][Full Text] [Related]
48. Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype? Sim SY; Chin SL; Tan JL; Brown SJ; Cussons AJ; Stuckey BG Fertil Steril; 2016 Oct; 106(5):1258-1263. PubMed ID: 27456547 [TBL] [Abstract][Full Text] [Related]
49. Screening women with polycystic ovary syndrome for metabolic syndrome. Dokras A; Bochner M; Hollinrake E; Markham S; Vanvoorhis B; Jagasia DH Obstet Gynecol; 2005 Jul; 106(1):131-7. PubMed ID: 15994628 [TBL] [Abstract][Full Text] [Related]
50. Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome. Armeni E; Lambrinoudaki I Curr Vasc Pharmacol; 2019; 17(6):579-590. PubMed ID: 30156159 [TBL] [Abstract][Full Text] [Related]
51. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
52. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway. Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267 [TBL] [Abstract][Full Text] [Related]
53. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349 [TBL] [Abstract][Full Text] [Related]
54. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Barber TM; Wass JA; McCarthy MI; Franks S Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468 [TBL] [Abstract][Full Text] [Related]
55. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study. Schmidt J; Dahlgren E; Brännström M; Landin-Wilhelmsen K Clin Endocrinol (Oxf); 2012 Aug; 77(2):207-14. PubMed ID: 22385110 [TBL] [Abstract][Full Text] [Related]
56. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome. Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591 [TBL] [Abstract][Full Text] [Related]
57. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196 [TBL] [Abstract][Full Text] [Related]
58. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS). Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473 [TBL] [Abstract][Full Text] [Related]
59. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome. Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312 [TBL] [Abstract][Full Text] [Related]
60. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. Puurunen J; Piltonen T; Morin-Papunen L; Perheentupa A; Järvelä I; Ruokonen A; Tapanainen JS J Clin Endocrinol Metab; 2011 Jun; 96(6):1827-34. PubMed ID: 21450988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]